🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 231269101
- Market Cap
- Small Cap
Business: Curis, Inc. is a drug development company that is committed to leveraging its innovative signaling pathway drug technologies to seek to create new targeted small molecule drug candidates for cancer. In expanding its drug development efforts in the field of cancer through its proprietary targeted cancer programs, Curis is building upon its previous experiences in targeting signaling pathways for the development of next generation targeted cancer therapies.
Company Contact
- CEO
- Rachel Blasbalg
- CFO
- Diantha Duvall
- Headquarters
- 128 Spring Street, Building C - Suite 500, Lexington, MA 02421
- Phone
- 617-503-6500
- Fax
- 617-503-6501
- Investor Relations
- Mani Mohindru · 617-503-6605 · mmohindru@curis.com